Unraveling Trimethoprim-Sulfonamide synergy against Escherichia coli through semi-mechanistic PK/PD modeling
Abstract
Trimethoprim/sulfonamide (TMP/S) is an antibiotic combination used in human and veterinary medicine for its synergistic effect. However, the recommended TMP/S dose ratio (1:5) in animals does not yield the targeted in vivo concentration ratio of 1:19, considered optimal for many human pathogens. Moreover, the diversity of TMP/S combinations used in veterinary medicine questions the relevance of a single universal ratio. Pharmacodynamic (PD) studies are therefore needed to characterize TMP/S time- and concentration-effect relationships. This study assessed three TMP/S combinations against three Escherichia coli strains using in vitro time-kill studies, with TMP and sulfonamides tested alone and in combination at multiple ratios. A semi-mechanistic pharmacokinetic (PK)/PD model was developed to quantify drug interactions and evaluated in a hollow-fiber infection model (HFIM) simulating poultry and equine PK for TMP/sulfadiazine (SDZ). Sulfonamides alone exhibited comparable maximal effects, lower than TMP alone. Bacterial regrowth was attributed to adaptive TMP resistance. Synergy was driven by TMP, reducing sulfonamide EC 50 values up to 92%. The most synergistic ratio was strain- and sulfonamide-dependent and differed from 1:19. HFIM results indicated that current TMP/SDZ dosing regimens are suboptimal in poultry but adequate in equine. Overall, these findings highlighted the importance of PK/PD-guided optimization for antibiotic combinations.
Related
- Quantitative Pharmacodynamic Analysis of Trimethoprim‐Sulfonamide Combination Activity Against Staphylococcus pseudintermedius
- Population pharmacokinetic modeling of sulfamethoxazole, sulfadiazine and sulfadimethoxine combined with trimethoprim in calves
- Unraveling the shared genetic architecture of metabolic bone diseases via genomic structural equation modeling and multi-omics integration
- Mechanistic modeling of bacterial translation initiation across growth conditions
- MIRCID: Inferred Hub-miRNAs Drive Cross-Task Improvements in Drug Mechanistic Modeling
BibTeX
@article{boulanger2026unraveling,
title = {{Unraveling Trimethoprim-Sulfonamide synergy against Escherichia coli through semi-mechanistic PK/PD modeling}},
author = {Marine Boulanger and Sadate Tchalaou and Andrew Mead and Ludovic Pelligand and Ophélie Gourbeyre and Felipe Ramon-Portugal and Lucie Claustre and Marlène Lacroix and Aude Ferran and Alexis Viel},
journal = {Scientific Reports},
year = {2026},
month = sep,
doi = {10.1038/s41598-026-73076-8},
url = {https://hal.science/hal-05767313v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Unraveling Trimethoprim-Sulfonamide synergy against Escherichia coli through semi-mechanistic PK/PD modeling
AU - Marine Boulanger
AU - Sadate Tchalaou
AU - Andrew Mead
AU - Ludovic Pelligand
AU - Ophélie Gourbeyre
AU - Felipe Ramon-Portugal
AU - Lucie Claustre
AU - Marlène Lacroix
AU - Aude Ferran
AU - Alexis Viel
PY - 2026
DA - 2026/09/25
JO - Scientific Reports
DO - 10.1038/s41598-026-73076-8
UR - https://hal.science/hal-05767313v1
AB - Trimethoprim/sulfonamide (TMP/S) is an antibiotic combination used in human and veterinary medicine for its synergistic effect. However, the recommended TMP/S dose ratio (1:5) in animals does not yield the targeted in vivo concentration ratio of 1:19, considered optimal for many human pathogens. Moreover, the diversity of TMP/S combinations used in veterinary medicine questions the relevance of a single universal ratio. Pharmacodynamic (PD) studies are therefore needed to characterize TMP/S time- and concentration-effect relationships. This study assessed three TMP/S combinations against three Escherichia coli strains using in vitro time-kill studies, with TMP and sulfonamides tested alone and in combination at multiple ratios. A semi-mechanistic pharmacokinetic (PK)/PD model was developed to quantify drug interactions and evaluated in a hollow-fiber infection model (HFIM) simulating poultry and equine PK for TMP/sulfadiazine (SDZ). Sulfonamides alone exhibited comparable maximal effects, lower than TMP alone. Bacterial regrowth was attributed to adaptive TMP resistance. Synergy was driven by TMP, reducing sulfonamide EC 50 values up to 92%. The most synergistic ratio was strain- and sulfonamide-dependent and differed from 1:19. HFIM results indicated that current TMP/SDZ dosing regimens are suboptimal in poultry but adequate in equine. Overall, these findings highlighted the importance of PK/PD-guided optimization for antibiotic combinations.
SN - 2045-2322
ER -